ARKG Holdings of SDGR
Schrödinger, Inc.
Schrödinger operates as a life sciences and materials science company, focusing on developing advanced computational platforms to accelerate drug discovery and materials research. The company generates revenue by licensing its proprietary software to pharmaceutical and biotechnology companies, as well as through collaborations and partnerships in drug discovery projects.
Trades of SDGR in ARKG
The ten most recent trades of Schrödinger, Inc. in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Nov 13, 2024 | Buy | $184,585 | 0.37% | 0.01% |
| Nov 12, 2024 | Buy | $4,185,270 | 9.25% | 0.30% |
| Sep 22, 2023 | Sell | $126,700 | 0.15% | 0.01% |
| Sep 21, 2023 | Sell | $1,495,456 | 1.75% | 0.08% |
| Sep 20, 2023 | Sell | $213,881 | 0.24% | 0.01% |
| Sep 19, 2023 | Sell | $79,808 | 0.09% | 0.00% |
| Sep 12, 2023 | Sell | $104,466 | 0.11% | 0.01% |
| Sep 11, 2023 | Sell | $1,804,338 | 1.76% | 0.09% |
| Aug 16, 2023 | Sell | $1,790,815 | 1.57% | 0.09% |
| Aug 15, 2023 | Sell | $3,323,881 | 2.73% | 0.16% |